NSC-139021
-
Catalog numberB2199-500
-
PricePlease ask
-
Size500 mg
-
-
Alternative_name1-(2-Thiazolylazo)-2-naphthol; 1-(2-Thiazoylazo)-2-naphthol; 1147-56-4; MLS000738280; 2-Naphthol, 1-(2-thiazolylazo); TAN
-
DescriptionNSC-139021 (ERGi-USU) is a highly selective inhibitor for the growth of ERG-positive cancer cells with IC₅₀s ranging from 30 to 400 nM. NSC-139021 displays minimal effect on normal prostate or endothelial cells or ERG-negative tumor cell lines.
-
CAS Number1147-56-4
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₃H₉N₃OS
-
Molecular Weight255.3
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA highly selective inhibitor for the growth of ERG-positive cancer cells
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD00021611
-
PubChem CID6308684
-
SMILESC1=CC=C2C(=C1)C=CC(=O)C2=NNC3=NC=CS3
-
InChiInChI=1S/C13H9N3OS/c17-11-6-5-9-3-1-2-4-10(9)12(11)15-16-13-14-7-8-18-13/h1-8H,(H,14,16)/b15-12-
-
InChi KeyGCBAKGGJQPMJLL-QINSGFPZSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameNSC-139021
-
Alternative nameNSC-139021
-